Favipiravir provides symptomatic relief from COVID, has mild side-effects, finds study by drug manufacturer
Results showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects like weakness, gastritis, diarrhoea, vomiting etc were found to be mild in nature
IMF chief economist Gita Gopinath flagged the "widening gap" as advanced economies grow faster and developing nations, especially in Asia, slow.
While e-cigarettes are relatively new, uncertainty about their longer-term effects do persist. But studies show that smoking disproportionately harms people
Compared to the uncertain strength and duration of immunity conferred by natural infection, the immunity conferred by the vaccine is stronger and will probably last longer
With telemedicine, access to proper healthcare will no longer be a problem for the average Indian citizen
54 percent of patients think telemedicine is not reliabile, 30 percent aren't comfortable with technology and data privacy is an area of concern along with regulatory approval for LEO-based internet access.
The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet "to be confirmed," according to the update available on WHO website.
According to the study published in the Indian Journal of Medical Research, the most common complication were a pre-term delivery and hypertensive disorders in pregnancy.
With lockdowns being eased and people getting back to normal life, there is a lot to worry about the potential third wave that could start soon.
Ebola can spread via fruit bats or from human to human contact: Everything you need to know about the virus
A vaccine developed by the US group Merck Sharp and Dohme was found to be very effective in a major study carried out in Guinea in 2015.
Ebola virus can lie dormant in survivors and trigger outbreaks even five years after infections: Study
Ebola outbreaks are usually thought to result from the virus "spilling" from an animal host to a human. But the analysis showed the Guinea strain was virtually identical to that from a 2013-16 wave.
The research, published in the journal Science, noted that this time point of six months is critical because that is when true immune memory has formed.
Six-feet distance may not be enough to prevent transmission of infectious aerosols indoors, finds study
According to the researchers, increasing the ventilation and air mixing rates can effectively reduce the transmission distance and potential accumulation of exhaled aerosols.
The consortium has called for more strongly implementing existing recommendations on sequencing of positive samples from international travellers.
The FDA said children that are part of the clinical trials "should be monitored for at least two months for side effects."
How will COVID-19 pandemic end? Nothing is certain but here's how the global health crisis will progress over the next year
Current evidence suggests SARS-CoV-2 is here to stay. Neither vaccines nor natural infection will stop the virus from spreading
More than 4.49 crore (4,49,03,025) balance and unutilised COVID-19 vaccine doses are still available with the states and UTs to be administered, the ministry said.
The authors noted that across all vaccine types and variants, vaccine efficacy is greater against severe disease than against mild disease.
The countrywide vaccination drive was rolled out on 16 January with healthcare workers getting inoculated in the first phase
Breakthrough infections: These four factors can increase the risk of vaccinated people getting COVID-19
The five most common symptoms of a breakthrough infection are a headache, a runny nose, sneezing, a sore throat and loss of smell.
They are also 4.5 times more likely than the fully vaccinated to get infected and over 10 times more likely to be hospitalized.